Rare exonic deletions implicate the synaptic organizer Gephyrin (GPHN) in risk for autism, schizophrenia and seizures - PubMed (original) (raw)
Clinical Trial
. 2013 May 15;22(10):2055-66.
doi: 10.1093/hmg/ddt056. Epub 2013 Feb 7.
Andrea K Vaags, Daisuke Sato, Matthew J Gazzellone, Elyse B Mitchell, Hong Yang Chen, Gregory Costain, Susan Walker, Gerald Egger, Bhooma Thiruvahindrapuram, Daniele Merico, Aparna Prasad, Evdokia Anagnostou, Eric Fombonne, Lonnie Zwaigenbaum, Wendy Roberts, Peter Szatmari, Bridget A Fernandez, Lyudmila Georgieva, Linda M Brzustowicz, Katharina Roetzer, Wolfgang Kaschnitz, John B Vincent, Christian Windpassinger, Christian R Marshall, Rosario R Trifiletti, Salman Kirmani, George Kirov, Erwin Petek, Jennelle C Hodge, Anne S Bassett, Stephen W Scherer
Affiliations
- PMID: 23393157
- DOI: 10.1093/hmg/ddt056
Clinical Trial
Rare exonic deletions implicate the synaptic organizer Gephyrin (GPHN) in risk for autism, schizophrenia and seizures
Anath C Lionel et al. Hum Mol Genet. 2013.
Abstract
The GPHN gene codes for gephyrin, a key scaffolding protein in the neuronal postsynaptic membrane, responsible for the clustering and localization of glycine and GABA receptors at inhibitory synapses. Gephyrin has well-established functional links with several synaptic proteins that have been implicated in genetic risk for neurodevelopmental disorders such as autism spectrum disorder (ASD), schizophrenia and epilepsy including the neuroligins (NLGN2, NLGN4), the neurexins (NRXN1, NRXN2, NRXN3) and collybistin (ARHGEF9). Moreover, temporal lobe epilepsy has been linked to abnormally spliced GPHN mRNA lacking exons encoding the G-domain of the gephyrin protein, potentially arising due to cellular stress associated with epileptogenesis such as temperature and alkalosis. Here, we present clinical and genomic characterization of six unrelated subjects, with a range of neurodevelopmental diagnoses including ASD, schizophrenia or seizures, who possess rare de novo or inherited hemizygous microdeletions overlapping exons of GPHN at chromosome 14q23.3. The region of common overlap across the deletions encompasses exons 3-5, corresponding to the G-domain of the gephyrin protein. These findings, together with previous reports of homozygous GPHN mutations in connection with autosomal recessive molybdenum cofactor deficiency, will aid in clinical genetic interpretation of the GPHN mutation spectrum. Our data also add to the accumulating evidence implicating neuronal synaptic gene products as key molecular factors underlying the etiologies of a diverse range of neurodevelopmental conditions.
Similar articles
- Exonic microdeletions of the gephyrin gene impair GABAergic synaptic inhibition in patients with idiopathic generalized epilepsy.
Dejanovic B, Lal D, Catarino CB, Arjune S, Belaidi AA, Trucks H, Vollmar C, Surges R, Kunz WS, Motameny S, Altmüller J, Köhler A, Neubauer BA, Epicure Consortium, Nürnberg P, Noachtar S, Schwarz G, Sander T. Dejanovic B, et al. Neurobiol Dis. 2014 Jul;67:88-96. doi: 10.1016/j.nbd.2014.02.001. Epub 2014 Feb 19. Neurobiol Dis. 2014. PMID: 24561070 - Isoform heterogeneity of the human gephyrin gene (GPHN), binding domains to the glycine receptor, and mutation analysis in hyperekplexia.
Rees MI, Harvey K, Ward H, White JH, Evans L, Duguid IC, Hsu CC, Coleman SL, Miller J, Baer K, Waldvogel HJ, Gibbon F, Smart TG, Owen MJ, Harvey RJ, Snell RG. Rees MI, et al. J Biol Chem. 2003 Jul 4;278(27):24688-96. doi: 10.1074/jbc.M301070200. Epub 2003 Apr 8. J Biol Chem. 2003. PMID: 12684523 - The GDP-GTP exchange factor collybistin: an essential determinant of neuronal gephyrin clustering.
Harvey K, Duguid IC, Alldred MJ, Beatty SE, Ward H, Keep NH, Lingenfelter SE, Pearce BR, Lundgren J, Owen MJ, Smart TG, Lüscher B, Rees MI, Harvey RJ. Harvey K, et al. J Neurosci. 2004 Jun 23;24(25):5816-26. doi: 10.1523/JNEUROSCI.1184-04.2004. J Neurosci. 2004. PMID: 15215304 Free PMC article. - Neurexins.
Reissner C, Runkel F, Missler M. Reissner C, et al. Genome Biol. 2013;14(9):213. doi: 10.1186/gb-2013-14-9-213. Genome Biol. 2013. PMID: 24083347 Free PMC article. Review. - Molecular and functional heterogeneity of GABAergic synapses.
Fritschy JM, Panzanelli P, Tyagarajan SK. Fritschy JM, et al. Cell Mol Life Sci. 2012 Aug;69(15):2485-99. doi: 10.1007/s00018-012-0926-4. Cell Mol Life Sci. 2012. PMID: 22314501 Free PMC article. Review.
Cited by
- Neurodevelopmental disorders: mechanisms and boundary definitions from genomes, interactomes and proteomes.
Mullin AP, Gokhale A, Moreno-De-Luca A, Sanyal S, Waddington JL, Faundez V. Mullin AP, et al. Transl Psychiatry. 2013 Dec 3;3(12):e329. doi: 10.1038/tp.2013.108. Transl Psychiatry. 2013. PMID: 24301647 Free PMC article. Review. - Whole-genome sequencing reveals principles of brain retrotransposition in neurodevelopmental disorders.
Jacob-Hirsch J, Eyal E, Knisbacher BA, Roth J, Cesarkas K, Dor C, Farage-Barhom S, Kunik V, Simon AJ, Gal M, Yalon M, Moshitch-Moshkovitz S, Tearle R, Constantini S, Levanon EY, Amariglio N, Rechavi G. Jacob-Hirsch J, et al. Cell Res. 2018 Feb;28(2):187-203. doi: 10.1038/cr.2018.8. Epub 2018 Jan 12. Cell Res. 2018. PMID: 29327725 Free PMC article. - Advancing the understanding of autism disease mechanisms through genetics.
de la Torre-Ubieta L, Won H, Stein JL, Geschwind DH. de la Torre-Ubieta L, et al. Nat Med. 2016 Apr;22(4):345-61. doi: 10.1038/nm.4071. Nat Med. 2016. PMID: 27050589 Free PMC article. Review. - Uncovering obsessive-compulsive disorder risk genes in a pediatric cohort by high-resolution analysis of copy number variation.
Gazzellone MJ, Zarrei M, Burton CL, Walker S, Uddin M, Shaheen SM, Coste J, Rajendram R, Schachter RJ, Colasanto M, Hanna GL, Rosenberg DR, Soreni N, Fitzgerald KD, Marshall CR, Buchanan JA, Merico D, Arnold PD, Scherer SW. Gazzellone MJ, et al. J Neurodev Disord. 2016 Oct 18;8:36. doi: 10.1186/s11689-016-9170-9. eCollection 2016. J Neurodev Disord. 2016. PMID: 27777633 Free PMC article. - HIV-1 Tat-Induced Astrocytic Extracellular Vesicle miR-7 Impairs Synaptic Architecture.
Hu G, Niu F, Liao K, Periyasamy P, Sil S, Liu J, Dravid SM, Buch S. Hu G, et al. J Neuroimmune Pharmacol. 2020 Sep;15(3):538-553. doi: 10.1007/s11481-019-09869-8. Epub 2019 Aug 10. J Neuroimmune Pharmacol. 2020. PMID: 31401755 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical